Alcohol use and clinical manifestations of tuberculosis (DOI:10.1016/j.jinf.2008.08.011)

Journal of Infection

Volumn 58, Issue 5, 2009, Pages 395-401

  Fiske, Christina T ^a   Hamilton, Carol D ^a   Stout, Jason E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alcoholism; Epidemiology; Tuberculosis

Indexed keywords

ACID FAST BACTERIUM; ADULT; AGED; ALCOHOL ABUSE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL FEATURE; ERRATUM; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; PREVALENCE; SPUTUM SMEAR; THORAX RADIOGRAPHY; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOLISM; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 67349275620     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.02.015     Document Type: Erratum

References (32)

1. Anon. Trends in tuberculosis - United States, 2007. MMWR Morbidity and Mortality Weekly Report 57 (2008) 281-285
2. Buskin S.E., Gale J.L., Weiss N.S., and Nolan C.M. Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990. American Journal of Public Health 84 (1994) 1750-1756
3. Centers for Disease Control and Prevention. Appendix SUR I RVCT Form Completion Instructions version 1.20. Last updated on 2003. http://ftp.cdc.gov/pub/Software/TIMS/Documentation/Apx%20SUR%20I%20RVCT%20Form%20Completion%20Instructions.pdf [accessed on 20.05.06]
4. McNutt L.A., Wu C., Xue X., and Haffner J.P. Estimating the relative risk in cohort studies and clinical trials of common outcomes. American Journal of Epidemiology 157 (2003) 940-943
5. Walker G.A. Common statistical methods for clinical research with SAS examples. 2nd ed. (2002), SAS Institute Inc., Cary, NC
6. Haddad M.B., Wilson T.W., Ijaz K., Marks S.M., and Moore M. Tuberculosis and homelessness in the United States, 1994-2003. JAMA 293 (2005) 2762-2766
7. Fleming M.F., Krupitsky E., Tsoy M., Zvartau E., Brazhenko N., Jakubowiak W., et al. Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. International Journal of Tuberculosis and Lung Disease 10 (2006) 565-570
8. Moran A., Harbour D.V., Teeter L.D., Musser J.M., and Graviss E.A. Is alcohol use associated with cavitary disease in tuberculosis?. Alcoholism, Clinical and Experimental Research 31 (2007) 33-38
9. Rodrigo T., Cayla J.A., Garcia d.O., Galdos-Tanquis H., Jansa J.M., Miranda P., et al. Characteristics of tuberculosis patients who generate secondary cases. International Journal of Tuberculosis and Lung Disease 1 (1997) 352-357
10. Wang C.S., Chen H.C., Chong I.W., Hwang J.J., and Huang M.S. Predictors for identifying the most infectious pulmonary tuberculosis patient. Journal of the Formosan Medical Association 107 (2008) 13-20
11. True W.R., Xian H., Scherrer J.F., Madden P.A., Bucholz K.K., Heath A.C., et al. Common genetic vulnerability for nicotine and alcohol dependence in men. Archives of General Psychiatry 56 (1999) 655-661
12. Altet-Gomez M.N., Alcaide J., Godoy P., Romero M.A., and Hernandez del Rey I. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. International Journal of Tuberculosis and Lung Disease 9 (2005) 430-436
13. Bates M.N., Khalakdina A., Pai M., Chang L., Lessa F., and Smith K.R. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Archives of Internal Medicine 167 (2007) 335-342
14. Leung C.C., Li T., Lam T.H., Yew W.W., Law W.S., Tam C.M., et al. Smoking and tuberculosis among the elderly in Hong Kong. American Journal of Respiratory and Critical Care Medicine 170 (2004) 1027-1033
15. Arcavi L., and Benowitz N.L. Cigarette smoking and infection. Archives of Internal Medicine 164 (2004) 2206-2216
16. Happel K.I., and Nelson S. Alcohol, immunosuppression, and the lung. Proceedings of the American Thoracic Society 2 (2005) 428-432
17. Vander Top E.A., Wyatt T.A., and Gentry-Nielsen M.J. Smoke exposure exacerbates an ethanol-induced defect in mucociliary clearance of Streptococcus pneumoniae. Alcoholism, Clinical and Experimental Research 29 (2005) 882-887
18. Vander Top E.A., Perry G.A., Snitily M.U., and Gentry-Nielsen M.J. Smoke exposure and ethanol ingestion modulate intrapulmonary polymorphonuclear leukocyte killing, but not recruitment or phagocytosis. Alcohol, Clinical and Experimental Research 30 (2006) 1599-1607
19. Mazzarella G., Bianco A., Perna F., et al. T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis. Clinical and Experimental Immunology 132 (2003) 283-288
20. Anon. Tuberculosis transmission in a homeless shelter population - New York, 2000-2003. MMWR Morbidity and Mortality Weekly Report 54 (2005) 149-152
21. Anon. Public health dispatch: tuberculosis outbreak among homeless persons - King County, Washington, 2002-2003. MMWR Morbidity and Mortality Weekly Report 52 (2003) 1209-1210
22. Kiwuwa M.S., Charles K., and Harriet M.K. Patient and health service delay in pulmonary tuberculosis patients attending a referral hospital: a cross-sectional study. BMC Public Health 5 (2005) 122
23. van der Werf M.J., Chechulin Y., Yegorova O.B., Marcinuk T., Stopolyanskiy A., Voloschuk V., et al. Health care seeking behaviour for tuberculosis symptoms in Kiev City, Ukraine. International Journal of Tuberculosis and Lung Disease 10 (2006) 390-395
24. Burman W.J., Cohn D.L., Rietmeijer C.A., Judson F.N., Sbarbaro J.A., and Reves R.R. Short-term incarceration for the management of noncompliance with tuberculosis treatment. Chest 112 (1997) 57-62
25. Santha T., Garg R., Frieden T.R., Chandrasekaran V., Subramani R., Gopi P.G., et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. International Journal of Tuberculosis and Lung Disease 6 (2002) 780-788
26. Sterling T.R., Zhao Z., Khan A., Chaisson R.E., Schluger N., Mangura B., et al. Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. International Journal of Tuberculosis and Lung Disease 10 (2006) 542-549
27. Diel R., and Niemann S. Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001. International Journal of Tuberculosis and Lung Disease 7 (2003) 124-131
28. Pablos-Mendez A., Knirsch C.A., Barr R.G., Lerner B.H., and Frieden T.R. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. American Journal of Medicine 102 (1997) 164-170
29. Weis S.E., Slocum P.C., Blais F.X., King B., Nunn M., Matney G.B., et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. New England Journal of Medicine 330 (1994) 1179-1184
30. Anon. Racial disparities in tuberculosis-selected southeastern states, 1991-2002. MMWR Morbidity and Mortality Weekly Report 53 (2004) 556-559
31. Stout J.E., Ratard R., Southwick K.L., and Hamilton C.D. Epidemiology of human immunodeficiency virus testing among patients with tuberculosis in North Carolina. Southern Medical Journal 95 (2002) 231-238
32. Hoyer G., Nilssen O., Brenn T., and Schirmer H. The Svalbard study 1988-89: a unique setting for validation of self-reported alcohol consumption. Addiction 90 (1995) 539-544